Anebulo Pharmaceuticals, Inc.
ANEB
$2.27
-$0.06-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 637.42% | 275.79% | 158.01% | 125.73% | -83.52% |
| Total Receivables | -96.01% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -45.41% | -36.83% | 136.03% | 113.34% | -40.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 436.84% | 241.01% | 157.09% | 125.86% | -78.31% |
|
|
|||||
| Total Current Assets | 436.84% | 241.01% | 157.09% | 125.86% | -78.31% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -67.21% | -67.60% | -67.91% | -34.89% | -- |
| Total Assets | 333.61% | 198.19% | 133.65% | 111.19% | -72.72% |
|
|
|||||
| Total Accounts Payable | 140.98% | 43.35% | 11.09% | 0.25% | -55.45% |
| Total Accrued Expenses | 12.36% | 152.88% | -81.05% | -19.51% | 110.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 69.33% | 87.15% | -45.96% | -13.30% | -20.57% |
|
|
|||||
| Total Current Liabilities | 69.33% | 87.15% | -45.96% | -13.30% | -20.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 69.33% | 87.15% | -45.96% | -13.30% | -20.57% |
|
|
|||||
| Common Stock & APIC | 23.42% | 23.59% | 23.42% | 23.43% | 2.19% |
| Retained Earnings | -12.49% | -12.97% | -12.01% | -12.29% | -13.27% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 412.84% | 205.78% | 170.04% | 130.64% | -77.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 412.84% | 205.78% | 170.04% | 130.64% | -77.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 412.84% | 205.78% | 170.04% | 130.64% | -77.21% |
|
|
|||||